BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 26261257)

  • 21. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma.
    Yeh YC; Kadota K; Nitadori J; Sima CS; Rizk NP; Jones DR; Travis WD; Adusumilli PS
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):e9-e15. PubMed ID: 26377636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma.
    Zhang Y; Li J; Wang R; Li Y; Pan Y; Cai D; Hu H; Li H; Ye T; Luo X; Zhang Y; Li B; Shen L; Sun Y; Chen H
    Sci Rep; 2014 Nov; 4():7163. PubMed ID: 25418354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitosis trumps T stage and proposed international association for the study of lung cancer/american thoracic society/european respiratory society classification for prognostic value in resected stage 1 lung adenocarcinoma.
    Duhig EE; Dettrick A; Godbolt DB; Pauli J; van Zwieten A; Hansen AR; Yang IA; Fong KM; Clarke BE; Bowman RV
    J Thorac Oncol; 2015 Apr; 10(4):673-81. PubMed ID: 25514800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma: a clinicopathologic study of 177 patients.
    Yang F; Chen K; Liao Y; Li X; Sun K; Bao D; Wang J
    World J Surg Oncol; 2014 Sep; 12():285. PubMed ID: 25216551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Factors of Survival after Recurrence in Patients with Resected Lung Adenocarcinoma.
    Hung JJ; Yeh YC; Jeng WJ; Chien HC; Wu YC; Chou TY; Hsu WH
    J Thorac Oncol; 2015 Sep; 10(9):1328-1336. PubMed ID: 26291011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
    Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
    J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
    Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
    J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society grading system has limited prognostic significance in advanced resected pulmonary adenocarcinoma.
    Westaway DD; Toon CW; Farzin M; Sioson L; Watson N; Brady PW; Marshman D; Mathur MM; Gill AJ
    Pathology; 2013 Oct; 45(6):553-8. PubMed ID: 24018816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma.
    Kadota K; Nitadori J; Sarkaria IS; Sima CS; Jia X; Yoshizawa A; Rusch VW; Travis WD; Adusumilli PS
    Cancer; 2013 Mar; 119(5):931-8. PubMed ID: 23096929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of histologic subtype in pStage I lung adenocarcinoma.
    Motono N; Matsui T; Machida Y; Usuda K; Uramoto H
    Med Oncol; 2017 Jun; 34(6):100. PubMed ID: 28432617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
    Kadota K; Villena-Vargas J; Yoshizawa A; Motoi N; Sima CS; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2014 Apr; 38(4):448-60. PubMed ID: 24472852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller.
    Nitadori J; Bograd AJ; Kadota K; Sima CS; Rizk NP; Morales EA; Rusch VW; Travis WD; Adusumilli PS
    J Natl Cancer Inst; 2013 Aug; 105(16):1212-20. PubMed ID: 23926067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) adenocarcinoma classification.
    Rodriguez EF; Monaco SE; Dacic S
    Cancer Cytopathol; 2013 Nov; 121(11):629-37. PubMed ID: 23943235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of outcomes for patients with lepidic pulmonary adenocarcinoma defined by 2 staging systems: A North American experience.
    Wilshire CL; Louie BE; Horton MP; Castiglioni M; Aye RW; Farivar AS; West HL; Gorden JA; Vallières E
    J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1561-8. PubMed ID: 26897242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.
    de Melo AC; Karen de Sá V; Sternberg C; Olivieri ER; Werneck da Cunha I; Fabro AT; Carraro DM; de Barros e Silva MJ; Pimenta Inada HK; de Mello ES; Soares FA; Takagaki T; Ferreira CG; Capelozzi VL
    Oncology; 2015; 89(3):175-86. PubMed ID: 25833149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease.
    Arrieta O; Salas AA; Cardona AF; Díaz-García D; Lara-Mejía L; Escamilla I; García AP; Pérez EC; Raez LE; Rolfo C; Rosell R
    Lung Cancer; 2021 May; 155():183-190. PubMed ID: 33558063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy.
    Leeman JE; Rimner A; Montecalvo J; Hsu M; Zhang Z; von Reibnitz D; Panchoo K; Yorke E; Adusumilli PS; Travis W; Wu AJ
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):138-145. PubMed ID: 27839909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary adenocarcinoma of the lung--histological subtypes and outcome after surgery, using the IASLC/ATS/ERS classification of lung adenocarcinoma.
    Oskarsdottir GN; Bjornsson J; Jonsson S; Isaksson HJ; Gudbjartsson T
    APMIS; 2016 May; 124(5):384-92. PubMed ID: 26957057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Solid Minor Histologic Subtype in Postsurgical Prognosis of Stage I Lung Adenocarcinoma.
    Chen T; Luo J; Gu H; Gu Y; Huang Q; Wang Y; Zheng J; Yang Y; Chen H
    Ann Thorac Surg; 2018 Jan; 105(1):302-308. PubMed ID: 29162222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.
    Kadota K; Colovos C; Suzuki K; Rizk NP; Dunphy MP; Zabor EC; Sima CS; Yoshizawa A; Travis WD; Rusch VW; Adusumilli PS
    Ann Surg Oncol; 2012 Oct; 19(11):3598-605. PubMed ID: 22644511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.